<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec3.2" class="sec">
 <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2</span>
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">General procedure for the synthesis of N-propargyl-1,2,3,4-THQs</div>
 <p id="p0090" xmlns="http://www.w3.org/1999/xhtml">THQ derivatives were efficiently synthesized according to methodology reported previously (
  <a rid="bib24" ref-type="bibr" href="#bib24">Rodriguez et al., 2016</a>), the protocol outlined in 
  <a rid="fig1" ref-type="fig" href="#fig1">Fig. 1</a>. This protocol can be divided into two steps:
 </p>
 <sec id="sec3.2.1" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.1</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Step 1: preparation of 
   <span class="italic">N</span>-propargylamine
  </div>
  <p id="p0095" xmlns="http://www.w3.org/1999/xhtml">In a round-bottomed flask, a 5-mL solution in anhydrous DMF of the corresponding anilines 
   <span class="bold">1</span> (1.8 mmol), potassium iodide (0.1 mmol) and anhydrous sodium carbonate (2 mmol) was prepared and stirred constantly at 0 °C. A solution of propargyl bromide 
   <span class="bold">2</span> (1.0 mmol) in anhydrous DMF was added dropwise and the mixture was kept at 0 °C for 20 minutes. The reaction was allowed to stir at room temperature for 3–4 h, indicated on TLC. The reaction mixture was diluted with water and extracted with ethyl acetate (3 × 20 mL), the organic phase was separated and dried (Na
   <sub>2</sub>SO
   <sub>4</sub>), the solvent removed under vacuum and the resulting product was purified by column chromatography on silica gel, (petroleum ether: ethyl acetate) to obtain the pure 
   <span class="italic">N</span>-propargyl anilines 
   <span class="bold">3a-g</span>.
  </p>
 </sec>
 <sec id="sec3.2.2" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.2</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Step 2: preparation of 
   <span class="italic">N</span>-propargyl THQs
  </div>
  <p id="p0100" xmlns="http://www.w3.org/1999/xhtml">All the reactions were performed at room temperature. In a round bottom flask, a 5 mL solution in CH
   <sub>3</sub>CN of preformed 
   <span class="italic">N</span>-propargylaniline 
   <span class="bold">3a-g</span> (1.0 mmol) and formaldehyde (37% in methanol) 
   <span class="bold">4</span> (1.1 mmol) was prepared and stirred for 10 minutes. 5 mL solution of InCl
   <sub>3</sub> (20% mol) in CH
   <sub>3</sub>CN was then added. After 20 minutes a solution of 
   <span class="italic">N-</span>vinylformamide 
   <span class="bold">5</span> (1.1 mmol) in CH
   <sub>3</sub>CN was incorporated to the reaction mixture and was vigorously stirred. The resulting mixture was stirred for 3–4 h. After the workup, the final product was purified by column chromatography, eluted with the appropriate mixture of petroleum ether and ethyl acetate to afford pure THQs 
   <span class="bold">6a-g</span>.
  </p>
 </sec>
 <sec id="sec3.2.3" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.3</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6a)</span>
  </div>
  <p id="p0105" xmlns="http://www.w3.org/1999/xhtml">Coffee solid; m.p. 118–120 °C; Yield 51%; 
   <span class="bold">IR</span>: 3279, 3038, 2958, 2922, 2847, 1658, 1492, 751; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.20 (1H, s), 7.22–7.31 (2H, m), 6.82–6.88 (2H, m), 5.21–5.28 (1H, m), 4.19–4.26 (1H, dd, 
   <span class="italic">J</span> = 18.2, 1.7 Hz), 4.00–4.07 (1H, dd, 
   <span class="italic">J</span> = 18.2, 1.1 Hz), 3.32–3.39 (2H, m), 2.25–2.28 (1H, s), 2.15–2.24 (2H, m). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm):160.09, 144.57, 129.60, 129.17, 122.23, 118.11, 112.81, 79.01, 72.09, 45.24, 44.76, 40.72, 28.48; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 213.80 (24), 174.88 (10), 167.78 (100), 129.88 (20). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>13</sub>H
   <sub>14</sub>N
   <sub>2</sub>O: 214.11 uma.
  </p>
 </sec>
 <sec id="sec3.2.4" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.4</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(6-methyl-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6b)</span>
  </div>
  <p id="p0110" xmlns="http://www.w3.org/1999/xhtml">Orange solid; m.p. 134–136 °C; Yield 95%; 
   <span class="bold">IR</span>: 3278, 2951, 2923, 2854, 1655, 1506, 1380, 1328, 1230, 803; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.18 (1H, s), 6.97–7.05 (2H, m), 6.70 (1H, d, 
   <span class="italic">J</span> = 8.3 Hz), 5.16 (1H, d, 
   <span class="italic">J</span> = 6.1 Hz), 4.09–4.16 (1H, d, 
   <span class="italic">J</span> = 18.1 Hz), 3.88–3.95 (1H, d, 
   <span class="italic">J</span> = 18.1 Hz), 3.21–3.26 (2H, m), 2.22–2.24 (3H, s), 2.15 (1H, br), 1.99–2.14 (2H, m). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm): 160.04, 142.37, 130.11, 129.74, 127.53, 122.40, 113.11, 79.08, 72.08, 45.34, 44.66, 40.86, 28.75, 20.23; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 227.71 (38), 188.92 (10), 181.88 (100), 166.87 (12), 143.97 (24). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>14</sub>H
   <sub>16</sub>N
   <sub>2</sub>O: 228.13 uma.
  </p>
 </sec>
 <sec id="sec3.2.5" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.5</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(6-methoxy-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6c)</span>
  </div>
  <p id="p0115" xmlns="http://www.w3.org/1999/xhtml">Coffee solid; m.p. 110–112 °C; Yield 66%; 
   <span class="bold">IR</span>: 3262, 3231, 2953, 2917, 2845, 1653, 1501, 1460, 1374, 1048, 737; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.18 (1H, s), 6.80 (1H, dd, 
   <span class="italic">J</span> = 8.9, 3.0 Hz), 6.71–6.76 (2H, m), 5.17 (1H, dd, 
   <span class="italic">J</span> = 12.9, 5.1 Hz), 4.10 (1H, dd, 
   <span class="italic">J</span> = 18.1, 2.2 Hz), 3.90 (1H, dd, 
   <span class="italic">J</span> = 18.1, 2.3 Hz), 3.73 (3H, s), 3.18–3.22 (2H, m), 2.13–2.15 (1H, br), 2.04–2.23 (2H, m). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm): 160.05, 152.33, 138.91, 123.74, 115.25, 114.57, 114.51, 79.11, 72.20, 55.71, 45.55, 44.85, 41.22, 28.94; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 243.76 (80), 204.89 (12), 197.97 (100), 159.64 (28), 144.80 (16). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>14</sub>H
   <sub>16</sub>N
   <sub>2</sub>O
   <sub>2</sub>: 244.12 uma.
  </p>
 </sec>
 <sec id="sec3.2.6" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.6</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(6-ethyl-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6d)</span>
  </div>
  <p id="p0120" xmlns="http://www.w3.org/1999/xhtml">Beige solid; m.p. 116–118 °C; Yield 31%; 
   <span class="bold">IR</span>: 3273, 3231, 2951, 2923, 2849, 1648, 1506, 1376, 1331, 804; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.11 (1H, s), 7.03 (1H, d, 
   <span class="italic">J</span> = 8.1 Hz), 6.97 (1H, d, 
   <span class="italic">J</span> = 14.5 Hz), 6.71 (1H, d, 
   <span class="italic">J</span> = 8.4 Hz), 5.10–5.17 (1H, m), 4.11 (1H, d, 
   <span class="italic">J</span> = 18.1 Hz), 3.91 (1H, d, 
   <span class="italic">J</span> = 18.1 Hz), 3,18–33.26 (2H, m), 2.52 (2H, q, 
   <span class="italic">J</span> = 7.5 Hz), 2.15 (1H, t, 
   <span class="italic">J</span> = 6.6 Hz), 2.03–2.13 (2H, m), 1.18 (3H, t, 
   <span class="italic">J</span> = 7.6 Hz). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm): 160.15, 142.56, 133.99, 128.94, 128.50, 122.32, 113.02, 79.19, 72.11, 45.32, 44.70, 40.83, 28.74, 27.74, 15.74; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 242.03 (34), 195.93 (100), 181.81 (12), 157.78 (22). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>15</sub>H
   <sub>18</sub>N
   <sub>2</sub>O: 242.14 uma.
  </p>
 </sec>
 <sec id="sec3.2.7" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.7</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(6-bromo-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6e)</span>
  </div>
  <p id="p0125" xmlns="http://www.w3.org/1999/xhtml">White solid; m.p. 164–166 °C; Yield 52%; 
   <span class="bold">IR</span>: 3239, 3044, 2956, 2920, 2851, 1645, 1490, 1241, 891; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.19 (1H, s), 7.21–7.25 (2H, m), 6.62 (1H, d, 
   <span class="italic">J</span> = 9.1 Hz), 5.15 (1H, dd, 
   <span class="italic">J</span> = 11.4, 5.1 Hz)
   <span class="bold">,</span> 4.07 (1H, d, 
   <span class="italic">J</span> = 18.3 Hz
   <span class="bold">)</span>, 3.91 (1H, d, 
   <span class="italic">J</span>
   <span class="bold">=</span> 18.2 Hz), 3.26 (2H, t, 
   <span class="italic">J</span>
   <span class="bold">=</span> 5.6 Hz
   <span class="bold">)</span>, 2.13–2.17 (1H, br), 1.99–2.13 (2H, m). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm): 160.85, 143.81, 131.33, 131.03, 125.38, 114.35, 109.09, 78.92, 72.90, 45.90, 43.78, 40.71, 28.59; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 291.52 (40), 247.98 (100), 209.76 (28), 166.82 (62). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>13</sub>H
   <sub>13</sub>BrN
   <sub>2</sub>O: 292.02 uma.
  </p>
 </sec>
 <sec id="sec3.2.8" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.8</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(6-chloro-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6f)</span>
  </div>
  <p id="p0130" xmlns="http://www.w3.org/1999/xhtml">Beige solid; m.p. 158–160 °C; Yield 23%; 
   <span class="bold">IR</span>: 3231, 2949, 2914, 2842, 1643, 1494, 1387, 1331, 1238; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.21 (1H, s); 7.11–7.16 (2H, m), 6.69 (1H, d, 
   <span class="italic">J</span> = 9.0 Hz), 5.14–5.20 (1H, m), 4.10 (1H, d, 
   <span class="italic">J</span> = 18.2 Hz), 3.94 (1H, d, 
   <span class="italic">J</span> = 18.3 Hz), 3.20–3.25 (2H, m), 2.15–2.18 (1H, br), 2.02–2.15 (2H, m). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm): 160.09, 143.15, 129.19, 128.95, 123.86, 122.84, 114.16, 78.50, 72.37, 45.43, 44.48, 40.86, 28.43; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 247.78 (44), 208.85 (15), 201.64 (100), 166.90 (40). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>13</sub>H
   <sub>13</sub>ClN
   <sub>2</sub>O: 248.07 uma.
  </p>
 </sec>
 <sec id="sec3.2.9" class="sec">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3.2.9</span>
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">N-(6-fluoro-1-prop-2-ynyl-1,2,3,4-tetrahydro-quinolin-4-yl)formamide 
   <span class="bold">(6g)</span>
  </div>
  <p id="p0135" xmlns="http://www.w3.org/1999/xhtml">Beige solid; m.p. 144–146 °C; Yield 71%; 
   <span class="bold">IR</span>: 3273, 3257, 2954, 2915, 1650, 1503, 801; 
   <span class="sup">
    <span class="bold">1</span>
   </span>
   <span class="bold">H NMR</span> (400 MHz, CDCl
   <sub>3</sub>) δ (ppm): 8.19 (1H, s), 6.88–6.93 (2H, m), 6.67–6.73 (1H, m), 5.17 (1H, dd, 
   <span class="italic">J</span> = 13.2, 5.4 Hz), 4.08 (1H, dd, 
   <span class="italic">J</span> = 18.2, 2.2 Hz), 3.93 (1H, dd, 
   <span class="italic">J</span> = 18.2, 2.2 Hz), 3.21–3.26 (2H, m), 2.15–2.17 (1H, br), 1.99–2.20 (2H. m). 
   <span class="sup">
    <span class="bold">13</span>
   </span>
   <span class="bold">C NMR</span> (100 MHz, CDCl
   <sub>3</sub>) δ (ppm): 160.14, 141.04, 123.94, 115.78, 115.56, 114.13, 114.06, 78.74, 72.34, 45.67, 44.60, 41.16, 28.72; 
   <span class="bold">GC-MS m/z (rel. int. %):</span> 231.80 (28), 192.85 (10), 185.78 (100), 147.74 (30). 
   <span class="italic">Anal. Calc. for</span> C
   <sub>13</sub>H
   <sub>13</sub>FN
   <sub>2</sub>O: 232.10 uma.
  </p>
 </sec>
</sec>
